| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
CDT Equity Inc.
13G
CDT · 20678X502
|
1.6% |
5/20/2026
Event 2/19/2026
|
||||
| Nirland Limited | 1.6% | |||||
| Stockton Limited | 1.6% | |||||
| The Rowland Master Trust | 1.6% | |||||
| Dovet Limited | 1.6% | |||||
|
Conduit Pharmaceuticals Inc.
13G/A
CDT · 20678X106
|
0% |
2/20/2025
Event 2/19/2025
|
||||
| Nirland Limited | 0% | |||||
| Stockton Limited | 0% | |||||
| The Rowland Master Trust | 0% | |||||
| Dovet Limited | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.